newsfilter
← Latest News
GlobeNewswire·

Orchard Therapeutics Provides Business Update and Reports 2022 Financial Results

OTL-200 pre-BLA meeting granted for second quarter of 2023 following productive clinical Type B meeting with the U.S. Food and Drug Administration (FDA) Strategic financing from leading healthcare investors provides up